Page last updated: 2024-11-09

1-butyl-3-methylimidazolium trifluoromethanesulfonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-butyl-3-methylimidazolium trifluoromethanesulfonate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2734246
CHEMBL ID3183478
SCHEMBL ID192398
MeSH IDM0526061

Synonyms (34)

Synonym
1-butyl-3-methylimidazolium trifluoromethanesulfonate, >=95.0% (h-nmr)
174899-66-2
1-butyl-3-methylimidazolium trifluoromethanesulfonate
b2337 ,
nsc746783
nsc-746783
NCGC00260167-01
tox21_202619
dtxsid0049232 ,
dtxcid2029088
cas-174899-66-2
1-butyl-3-methylimidazolium trifluoromethansulfonate
FT-0608143
AKOS015904066
bmim otf
SCHEMBL192398
1-butyl-3-methylimidazolium triflate
1-butyl-3-methylimidazoliumtrifluoromethanesulfonate
Q-102679
CHEMBL3183478
1-butyl-3-methylimidazolium trifluoromethanesulfonate, 97%
mfcd03427620
SY062306
1-butyl-3-methyl-imidazol-3-ium trifluoromethanesulfonate
BS-16059
1-butyl-3-methylimidazol-3-ium;trifluoromethanesulfonate
1-butyl-3-methyl-1h-imidazol-3-ium trifluoromethanesulfonate
AC8235
1-n-butyl-3-methylimidazolium triflate
A881651
1-butyl-3-methylimidazolium trifluoromethansulfonate [bmim]otf
1-butyl-3-methylimidazolium trifluoromethanesulphonate
nsc 746783
CS-W012210
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency63.57060.002541.796015,848.9004AID1347395
GLI family zinc finger 3Homo sapiens (human)Potency15.43340.000714.592883.7951AID1259369
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency68.93850.000627.21521,122.0200AID743202
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's8 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.78 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]